CN113952249A - 一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 - Google Patents
一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 Download PDFInfo
- Publication number
- CN113952249A CN113952249A CN202111262259.XA CN202111262259A CN113952249A CN 113952249 A CN113952249 A CN 113952249A CN 202111262259 A CN202111262259 A CN 202111262259A CN 113952249 A CN113952249 A CN 113952249A
- Authority
- CN
- China
- Prior art keywords
- phase
- parts
- derivatives
- volume
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 43
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 21
- 235000010323 ascorbic acid Nutrition 0.000 title claims abstract description 18
- 239000011668 ascorbic acid Substances 0.000 title claims abstract description 18
- 230000002779 inactivation Effects 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 24
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- -1 polydimethylsiloxane Polymers 0.000 claims description 7
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 6
- 239000002480 mineral oil Substances 0.000 claims description 6
- 235000010446 mineral oil Nutrition 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- 239000007788 liquid Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000009849 deactivation Effects 0.000 abstract 1
- 238000011049 filling Methods 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 4
- KIUKXJAPPMFGSW-YXBJCWEESA-N (2s,4s,5r,6s)-6-[(2s,3r,5s,6r)-3-acetamido-2-[(3s,4r,5r,6r)-6-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@@H]3[C@@H]([C@@H](O)C(O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)C(C(O)=O)O1 KIUKXJAPPMFGSW-YXBJCWEESA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical group CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案,化妆品由A相(水剂)、B相(油剂+粉末)两类物料构成。由油剂和以VC及其衍生物中的一种或多种为主的干粉构成的B相,有效解决VC在水剂中存在的快速失活、变色等问题;B相的构成形式,便于使用时方便地将部分B相与部分A相混合,形成化妆品使用液,剩余A、B相仍为分隔状态,不会互相影响;解决了抗坏血酸类产品存储时的不稳定问题。使用时仅需泵出部分混合,A、B相的其他部分仍单独存放,互不干扰,保证使用时的每一滴均为新鲜混合,提升了用户体验,因VC活性获得了百分之百的封存,使得其护肤功能充分发挥,保证了护肤效果,具有很强的实用性和广泛的适用性。
Description
技术领域
本发明涉及一种解决抗坏血酸易失活的化妆品,具体涉及一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案。
背景技术
抗坏血酸,即维生素c(简称VC)是一种水溶性维生素,其具有非常优秀的抗氧化、美白、抗皱、抗衰老,促进皮肤胶原新生等众多美容护肤功能。
但因维生素c过于不稳定,特别是在水溶液中很快分解并失活变色。对产品稳定性和护肤体验造成很大挑战。
目前,市售的产品均存在此问题,部分产品中添加丙二醇,丁二醇等多元醇配合维生素E等抗氧成分,以减缓维生素c的氧化速度;也有将产品两瓶分装:一瓶水剂、一瓶VC粉末,使用前进行溶解,但溶解为一次过程,溶解成为液体后,使用过程VC仍然会快速失活,变色。
因此目前抗坏血酸的使用,一直是在接受其变色的情况下的应用,体验较差,产品质量管控难,且产品效果不稳定。
发明内容
为解决现有技术的不足,本发明的目的在于提供一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案。
为了实现上述目标,本发明采用如下的技术方案:
一种多相态解决抗坏血酸及其衍生物易失活化妆品的技术方案,将分装于第一储腔和第二储腔的A相和B相同时泵出后混合;
所述A相为水剂,B相包括混溶于油剂中的粉末,所述粉末包括VC及其衍生物。
上述A相包括An(n>1)相,且An相分装于第n支腔内。
上述B相包括Bm(m>1)相,且Bm相分装于第m支腔内。
一种多相态解决抗坏血酸及其衍生物易失活的化妆品,包括A相和B相;
所述A相为水剂,包括水、丙二醇、透明质酸溶液,及甘油和/或乙氧基二甘醇;
所述B相包括混溶于油剂中的粉末;
所述油剂包括聚二甲基硅氧烷,或及矿物油、植物油;粉末包括VC及其衍生物。
按体积份,所述A相为10-90份,B相中的油剂为1-90份;
所述粉末占总质量的0.1-90%。
按体积份,上述水为3-80份,丙二醇为3-5份,透明质酸溶液为0.01-1份,甘油为3-9份,乙氧基二甘醇为3-9份。
按体积份,上述油剂中的聚二甲基硅氧烷为0.5-80份、矿物油为0.2-8份、植物油为0.2-8份。
按体积份,上述B相中还包括环五硅氧烷,其体积份为4-8份。
本发明的有益之处在于:
本发明的一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案,化妆品由A相(水剂)、B相(油剂+粉末)两类物料构成。其中的B相由油剂和以VC及其衍生物为主的干粉构成,可有效解决VC及其衍生物在水剂中存在的快速失活、变色等问题;B相的构成形式,便于使用时方便地将部分B相与部分A相混合,形成化妆品使用液,剩余A、B相仍为分隔状态,不会互相影响;区别于目前已有的由含VC干粉和营养液的产品,解决了该类产品使用前只能一次混合,混合后即成为液态化妆品,导致其中的VC成分已处于易变色、失活的状态。
本发明的化妆品,解决了抗坏血酸及其衍生物产品存储时的不稳定问题,将易影响VC活性的水剂成分,与油剂及VC粉末隔离。使用时仅需泵送出部分混合,A、B相的其他部分仍单独存放,互不干扰,保证使用时的每一滴均为新鲜混合;从而解决了使用和存储时产生的互相干扰活性状态等问题,也提升了用户体验,因VC活性获得了百分之百的封存,使得其护肤功能充分发挥,保证了护肤效果,具有很强的实用性和广泛的适用性。
附图说明
图1为A、B两相时的分装结构示意图。
图2为A、B多相时的分装结构示意图。
附图中标记的含义如下:1、出料管,2、第一汲料管,3、第二汲料管,4、第一储腔,5、第二储腔。
具体实施方式
以下结合具体实施例对本发明作具体的介绍。
一种多相态解决抗坏血酸及其衍生物易失活的化妆品,由A相和B相组成。
A相为10-90体积份的水剂;由3-80体积份的水、3-5体积份的丙二醇、0.01-1体积份的透明质酸溶液,及3-9体积份的甘油和/或3-9体积份的乙氧基二甘醇组成。
B相由1-90体积份的油剂,和混溶于油剂中的粉末组成;粉末为VC及其衍生物,占化妆品总质量的0.1-90%。
其中,油剂由0.5-80体积份的聚二甲基硅氧烷,或及0.2-8体积份的矿物油、0.2-8体积份的植物油;B相中还包括4-8体积份的环五硅氧烷。
技术方案:
方案一:为将A相和B相分装于如图1所示的储存装置的第一储腔4和第二储腔5内,第一储腔4和第二储腔5相互隔离。压泵的泵管由连通的出料管1和汲料管组成,其中汲料管包括并联的第一汲料管2和第二汲料管3,且第一汲料管2置入第一储腔4内,第二汲料管3置入第二储腔5内;泵压后,第一汲料管2和第二汲料管3同时汲取A相和B相,汇于出料管后,泵出。
实际使用时,根据储存装置的结构,也可省略出料管1,A相和B相泵出后于手心搓糅混合后构成化妆品成品使用。
方案二:
在方案一的基础上,根据A相的组分,将A相分为若干相,即An(n>1)相。同时,将储存装置的第一储腔4分为n个支腔,第An相装于第n支腔内;且,第一汲料管由n个并联的汲料分管组成,第n个汲料分管置于第n支腔内。
同上,根据B相的组分,将B相分为若干相,即Bm(m>1)相。同时,将储存装置的第二储腔5分为m个支腔,第Bm相装于第m支腔内;且,第一汲料管由m个并联的汲料分管组成,第m个汲料分管置于第m支腔内。VC混于至少一个第Bm相中。
如图2所示,m=n=2。
实施例1
组相 | 组分 | 体积份 | 质量占比(%) |
A相 | 水 | 45.95 | |
甘油 | 5 | ||
丙二醇 | 4 | ||
透明质酸钠 | 0.05 | ||
B相 | 聚二甲基硅氧烷 | 30 | |
维生素C | 10 | ||
环五硅氧烷 | 5 |
制备方法:
S1、A相混合,加热溶解至透明液体,冷却至室温,待灌装;
S2、依次称取B相的组分,混合均匀,适当高速均质,促进VC粉末的均匀分散,待灌装;
S3、将A、B相灌装至如图1所示的包装瓶内部的不同分腔中。必要情况下,B相灌装时,灌装设备配备搅拌装置,保证VC粉末的均匀分散。
经检验合格,为实施例1的化妆品。
实施例2
下表所列出的是实施例2的成分构成。实施例2的水剂A相部分,为保证不同功效成分不互相影响,将A相分为A1、A2两个组分相。
组相 | 组分 | 体积份 | 质量占比(%) |
A1相 | 水 | 26.75 | |
A2相 | 乙氧基二甘醇 | 5 | |
丙二醇 | 4 | ||
透明质酸钠 | 0.05 | ||
海藻糖 | 1 | ||
汉生胶 | 0.2 | ||
B1相 | 聚二甲基硅氧烷 | 30 | |
维生素C | 20 | ||
B2相 | 环五硅氧烷 | 5 | |
白矿油 | 5 | ||
辛酸癸酸甘油酯 | 3 |
制备方法:
S1、A相混合,加热溶解至透明液体,冷却至室温,待灌装;
S2、B相依次称取,混合均匀,适当高速均质,促进VC粉末的均匀分散;待灌装;
S3、将A、B相分别灌装至如图2所示的包装瓶内部的不同分隔中。必要情况下,B1相灌装时,灌装设备配备搅拌装置,保证VC粉末的均匀分散。
经检验合格,为实施例2的化妆品。
本发明不仅限于抗坏血酸这单一成分的保护,也可应用于维C衍生物,比如维C乙基醚、维C磷酸酯钠等,也可应用于视黄醇及其衍生物,或是其他不稳定成分的保护。
以上显示和描述了本发明的基本原理、主要特征和优点。本行业的技术人员应该了解,上述实施例不以任何形式限制本发明,凡采用等同替换或等效变换的方式所获得的技术方案,均落在本发明的保护范围内。
Claims (8)
1.一种多相态解决抗坏血酸及其衍生物易失活化妆品的技术方案,其特征在于,将分装于第一储腔和第二储腔的A相和B相同时泵出后混合;
所述A相为水剂,B相包括混溶于油剂中的粉末,所述粉末包括VC及其衍生物中的一种或多种。
2.根据权利要求1所述的技术方案,其特征在于,所述A相包括An(n>1)相,且An相分装于第n支腔内。
3.根据权利要求1所述的技术方案,其特征在于,所述B相包括Bm(m>1)相,且Bm相分装于第m支腔内。
4.一种多相态解决抗坏血酸及其衍生物易失活的化妆品,其特征在于,适用于权利要求1-3任一项所述的技术方案,包括A相和B相;
所述A相为水剂,包括水、丙二醇、透明质酸溶液,及甘油和/或乙氧基二甘醇;
所述B相包括混溶于油剂中的粉末;
所述油剂包括聚二甲基硅氧烷,或及矿物油、植物油;粉末包括VC及其衍生物中的一种或多种。
5.根据权利要求4所述的化妆品,其特征在于,按体积份,所述A相为10-90份,B相中的油剂为1-90份;
所述粉末占总质量的0.1-90%。
6.根据权利要求4所述的化妆品,其特征在于,按体积份,所述水为3-80份,丙二醇为3-5份,透明质酸溶液为0.01-1份,甘油为3-9份,乙氧基二甘醇为3-9份。
7.根据权利要求4所述的化妆品,其特征在于,按体积份,所述油剂中的聚二甲基硅氧烷为0.5-80份、矿物油为0.2-8份、植物油为0.2-8份。
8.根据权利要求4所述的化妆品,其特征在于,按体积份,所述B相中还包括环五硅氧烷,其体积份为4-8份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111262259.XA CN113952249A (zh) | 2021-10-28 | 2021-10-28 | 一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111262259.XA CN113952249A (zh) | 2021-10-28 | 2021-10-28 | 一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113952249A true CN113952249A (zh) | 2022-01-21 |
Family
ID=79467914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111262259.XA Pending CN113952249A (zh) | 2021-10-28 | 2021-10-28 | 一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113952249A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104188825A (zh) * | 2014-04-08 | 2014-12-10 | 广州奥蓓斯化妆品有限公司 | 一种美白霜及其制作方法 |
CN107405262A (zh) * | 2015-02-27 | 2017-11-28 | 东洋喷雾工业株式会社 | 双液混合型气溶胶制品 |
CN109875911A (zh) * | 2019-01-31 | 2019-06-14 | 张鹭云 | 一种易吸收的无水纳米维生素c面霜及其制备方法 |
-
2021
- 2021-10-28 CN CN202111262259.XA patent/CN113952249A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104188825A (zh) * | 2014-04-08 | 2014-12-10 | 广州奥蓓斯化妆品有限公司 | 一种美白霜及其制作方法 |
CN107405262A (zh) * | 2015-02-27 | 2017-11-28 | 东洋喷雾工业株式会社 | 双液混合型气溶胶制品 |
CN109875911A (zh) * | 2019-01-31 | 2019-06-14 | 张鹭云 | 一种易吸收的无水纳米维生素c面霜及其制备方法 |
Non-Patent Citations (1)
Title |
---|
张海州 等: "用于稳定化妆品中维生素C的油包多元醇体系的研究" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6322798B1 (en) | Cosmetic and/or dermatological composition with a hydrophilic carrier and vitamin C which can be mixed immediately before use | |
CN105287293A (zh) | 一种果皮酵素面膜及其制作方法 | |
US5620681A (en) | Self-tanning cosmetic composition | |
CN108697621A (zh) | 双相化妆品组合物及其外用用途 | |
CN107233221A (zh) | 一种双连续卸妆液及其制备方法 | |
KR20170033483A (ko) | 화장품용 천연 계면활성제 및 이를 포함하는 화장료 조성물 | |
US20220087908A1 (en) | Manufacture of freeze-dried cosmetic | |
TW201726100A (zh) | 錠型凍結乾燥化妝料 | |
CN113952249A (zh) | 一种多相态解决抗坏血酸及其衍生物易失活的化妆品及其技术方案 | |
JP2001206836A (ja) | 皮膚外用剤 | |
CN110680765A (zh) | 一种抗糖化精华及其制备方法 | |
CN101104015A (zh) | 橄榄软胶囊的原料配方及其制备工艺 | |
CN110037937A (zh) | 一种温和氨基酸洁面膏及其制备方法 | |
EP3028690B1 (en) | Cosmetic product for hair decoloring or hair coloring | |
CN114948772A (zh) | 一种虾青素纳米囊及其制备方法和应用 | |
JP6798149B2 (ja) | タウリン含有組成物 | |
CN105310937A (zh) | 一种滋润护手霜及其制作方法 | |
CN106420429A (zh) | 一种杜氏盐藻天然活性成分面膜及其制备方法 | |
JP5349719B2 (ja) | 皮膚外用剤 | |
JP2013227270A (ja) | 発泡性皮膚外用剤 | |
JP6884441B1 (ja) | 外用組成物 | |
CN110339144A (zh) | 一种除皱化妆品组合物及其加工方法 | |
JP7520342B2 (ja) | 染毛料組成物 | |
KR102387155B1 (ko) | 헤어케어용 실리콘 에멀젼 화장료 조성물 및 그 제조방법 | |
KR20130101822A (ko) | 염모제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220121 |
|
RJ01 | Rejection of invention patent application after publication |